The GlycoTech
Business Services · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
7860 Beechcraft Ave, Gaithersburg, Maryl...Phone Number
(301) 738-1080Website
www.glycotech.comRevenue
$5.4 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About The GlycoTech
GlycoTech has maintained a corporate alliance with Novartis for the past six years to develop small molecule mimics of carbohydrate ligands as potent antagonists for the aberrant extravasation of lymphocytes from the bloodstream during transplantation-induced reperfusion injury. In addition, licensing agreements were recently established with Chiron Corporation for worldwide sales in cancer diagnostics using anti-carbohydrate tumor markers owned by GlycoTech. Research agreements have also been established with the National Institutes of Health, the University of Pennsylvania, the University of Rochester, and the Chicago Institute for Neurosurgery and Neuroresearch. GlycoTech is actively seeking other pharmaceutical partners and offers a combined range of expertise focusing on the Glycobiology area. The corporate structure and strategy of GlycoTech allows its partners to quickly obtain this unique expertise and avoid the obligations encountered with the fixed financial responsibilitiesRead more
The GlycoTech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is The GlycoTech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if The GlycoTech had a recent Job posting/layoffs
The GlycoTech, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once The GlycoTech has new funding data
Earning: See what the market has to say on The GlycoTech recently announced quarterly report
Product Launch: Get notified when The GlycoTech launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at The GlycoTech
Check if The GlycoTech has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if The GlycoTech is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to The GlycoTech
Compare insights from companies similar to The GlycoTech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
The GlycoTech is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
The GlycoTech is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about The GlycoTech.
The GlycoTech Tech Stack
A closer look at the technologies used by The GlycoTech
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding The GlycoTech
Sign Up For FreeTo access detailed company insights
GlycoTech has maintained a corporate alliance with Novartis for the past six years to develop small molecule mimics of carbohydrate ligands as potent antagonists for the aberrant extravasation of lymphocytes from the bloodstream during transplantation-induced reperfusion injury. In addition, licensing agreements were recently established with Chiro... Read More
